Drugmakers Merck, Allergan Spark Rumors Of Biogen Takeover A Wall Street Journal report stokes speculations that biotech company Biogen is the acquisition target of two larger drugmakers. Allergan and Merck are each vying for the company. by Rachel Ranosa
Healthy Living/Wellness Hemophilia B drug Alprolix given the go-ahead in Canada, with U.S. approval imminent by Tabitha Laffernis